top of page
Joint Ventures in MENA Pharma: The Governance Decisions That Determine Whether Your JV Thrives or Fails
MENA pharma joint ventures fail predictably, and the failure mode is almost always built in at formation. Learn the governance decisions that determine JV success from day one. | Nexus Pharmalink
4 min read
The Bidirectional Pharma Partnership Model: How MENA Players Access Western Innovation
MENA pharma companies are actively seeking Western innovation, in-licensing, co-development, and biotech access. Discover the bidirectional partnership model that creates value for both sides. | Nexus Pharmalink
4 min read
Why 70% of Pharma Expansions Into MENA Fail And How to Avoid It
70% of pharma expansions into MENA fail. Discover the 4 critical mistakes and the Nexus approach to securing your market entry. Expert guide by Sara Abbad.
2 min read
bottom of page